Genovis Launches New Enzyme Product
Genovis is launching a further development of GingisKHAN® that will be marketed under the name GingisKHAN®Fab kit. The product will be presented at the conference Antibody Engineering & Therapeutics in San Diego next week. Read more »
Genovis AB (publ) to Publish Q3 2015 Report Ahead of Schedule
The Board of Directors of Genovis AB (publ) has decided to publish Q3 2015 report ahead of schedule. Read more »
Genovis is Reorganizing and Closing its Subsidiary GeccoDots
For the Group, the reorganization will entail cost and capital expenditure savings of approximately SEK 6 million over a 12-month period. All intangible and tangible assets have been transferred to the Parent Company, which decided to sell the intellectual property rights behind the Nanomotus project to the inventors against future royalties. Read more »